AKAM three-lens brief
Evidence-based stock research on AKAM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -3.27% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved -3.27% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $153.31 — 43% above current (23 analysts).
AKAM closed at $107.13 (-3.27%) as of 2026-09-11. Market cap: $15.40B. P/E (trailing) 40.1. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $153.31 — 43% above current (23 analysts).. Concerns: moved -3.27% yesterday.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $1.10B, net income $79.40M, free cash flow $710.06M.
Why three lenses on AKAM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AKAMacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AKAM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AKAM brief"></iframe>